NCT05762250 Auricular Acupuncture in Patients With Advanced Cancer: a Randomized Clinical Trial.
| NCT ID | NCT05762250 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Tuebingen |
| Condition | Fatigue |
| Study Type | INTERVENTIONAL |
| Enrollment | 125 participants |
| Start Date | 2023-08-13 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 125 participants in total. It began in 2023-08-13 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the present study, the effect of ear acupressure treatment according to the NADA protocol on the quality of life of patients with advanced tumour diseases. (all stages) will be investigated. Furthermore, the effect of ear acupressure on anxiety and depression, pain, fatigue and sleep of the patients will be assessed.
Eligibility Criteria
Inclusion Criteria: * Adult patients with advanced tumour diseases on current therapy, who suffer from persistent disease- or therapy-associated symptoms and limitations (screening by distress thermometer, score ≥ 5) * Informed consent. Exclusion Criteria: * medical reasons or * a mental condition which, in the opinion of the investigator, does not allow the patient to participate in the study, * a planned radiation therapy in the area of the skull (to avoid potential scattered radiation), * a missing legally binding signature on the informed consent form, * participation in another acupuncture/acupressure study.
Contact & Investigator
Claudia Loeffler, Dr
PRINCIPAL INVESTIGATOR
Wuerzburg University Hospital
Frequently Asked Questions
Who can join the NCT05762250 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Fatigue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05762250 currently recruiting?
Yes, NCT05762250 is actively recruiting participants. Contact the research team at loeffler_C@ukw.de for enrollment information.
Where is the NCT05762250 trial being conducted?
This trial is being conducted at Stuttgart, Germany, Würzburg, Germany.
Who is sponsoring the NCT05762250 clinical trial?
NCT05762250 is sponsored by University Hospital Tuebingen. The principal investigator is Claudia Loeffler, Dr at Wuerzburg University Hospital. The trial plans to enroll 125 participants.